
Genetic causes of vitamin D–related hypercalcemia are known to involve mutation of 25‐hydroxyvitamin D‐24‐hydroxylase CYP24A1 or the sodium phosphate co‐transporter SLC34A1, which result in excessive 1,25‐(OH)2D hormonal action. However, at least 20% of idiopathic hypercalcemia (IH) cases remain unresolved. In this case‐control study, we used precision vitamin D metabolite profiling based on liquid chromatography–tandem mass spectrometry (LC‐MS/MS) of an expanded range of vitamin D metabolites...
Like
Save
Share